BR112019013702A2 - Método de administração de compostos doadores de nitroxila - Google Patents
Método de administração de compostos doadores de nitroxila Download PDFInfo
- Publication number
- BR112019013702A2 BR112019013702A2 BR112019013702-5A BR112019013702A BR112019013702A2 BR 112019013702 A2 BR112019013702 A2 BR 112019013702A2 BR 112019013702 A BR112019013702 A BR 112019013702A BR 112019013702 A2 BR112019013702 A2 BR 112019013702A2
- Authority
- BR
- Brazil
- Prior art keywords
- hours
- donor compound
- cyclodextrin
- nitroxyl donor
- nitroxyl
- Prior art date
Links
- 0 *C(CC(*)=C1)C=C1S(NO*)(=C)=O Chemical compound *C(CC(*)=C1)C=C1S(NO*)(=C)=O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762441803P | 2017-01-03 | 2017-01-03 | |
| US62/441,803 | 2017-01-03 | ||
| US201762549932P | 2017-08-24 | 2017-08-24 | |
| US62/549,932 | 2017-08-24 | ||
| PCT/US2018/012114 WO2018128999A1 (en) | 2017-01-03 | 2018-01-02 | Method of administering nitroxyl donating compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019013702A2 true BR112019013702A2 (pt) | 2020-03-03 |
Family
ID=61224497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019013702-5A BR112019013702A2 (pt) | 2017-01-03 | 2018-01-02 | Método de administração de compostos doadores de nitroxila |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11083704B2 (https=) |
| EP (1) | EP3565544A1 (https=) |
| JP (1) | JP2020503356A (https=) |
| KR (1) | KR20190103281A (https=) |
| CN (1) | CN110520116A (https=) |
| AU (1) | AU2018205621B2 (https=) |
| BR (1) | BR112019013702A2 (https=) |
| CA (1) | CA3049003A1 (https=) |
| IL (1) | IL267728A (https=) |
| MX (1) | MX388684B (https=) |
| SG (2) | SG10202107533RA (https=) |
| WO (1) | WO2018128999A1 (https=) |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1024524A (en) | 1910-08-06 | 1912-04-30 | Lanston Monotype Machine Co | Type-casting machine. |
| US1058314A (en) | 1911-02-20 | 1913-04-08 | B F Cummins Company | Separating mechanism for mail-matter. |
| US1048704A (en) | 1911-04-29 | 1912-12-31 | King Construction Company | Clip for connecting rafters, purlins, and sash-bars of greenhouses. |
| US1017976A (en) | 1911-08-25 | 1912-02-20 | Rudolph Koch | Automatic mail-bag catcher and deliverer. |
| US1021340A (en) | 1911-10-14 | 1912-03-26 | William A Scott | Means for attaching binding-posts to dry batteries. |
| US1051784A (en) | 1912-02-16 | 1913-01-28 | Martin Trewhitt | Brooder. |
| US5998458A (en) * | 1997-06-25 | 1999-12-07 | University Technology Corporation | Method of treating heart failure |
| US20040038947A1 (en) | 2002-06-14 | 2004-02-26 | The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services | Method of treating ischemia/reperfusion injury with nitroxyl donors |
| US6936639B2 (en) | 2002-08-21 | 2005-08-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitroxyl progenitors in the treatment of heart failure |
| WO2005074598A2 (en) | 2004-01-30 | 2005-08-18 | Johns Hopkins University | Nitroxyl progenitor compounds and methods of use |
| US20090298795A1 (en) | 2005-06-23 | 2009-12-03 | The Johns Hopins University | Thiol-Sensitive Positive Inotropes |
| US8030356B2 (en) | 2006-03-17 | 2011-10-04 | Cardioxyl Pharmaceuticals, Inc. | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| US7696373B2 (en) | 2006-04-13 | 2010-04-13 | Wake Forest University Health Sciences | C-nitroso-derived nitroxyl donors |
| CN104119310B (zh) | 2007-09-26 | 2017-04-12 | 约翰斯霍普金斯大学 | 作为新的在生理学上可用于硝酰基供体的n‑羟基磺酰胺衍生物及包含其的医药组合物 |
| EP3067352A3 (en) | 2008-05-07 | 2016-10-19 | Cardioxyl Pharmaceuticals Inc. | Novel nitroso compounds as nitroxyl donors and methods of use thereof |
| US20110160200A1 (en) | 2009-11-23 | 2011-06-30 | Cardioxyl Pharmaceuticals, Inc. | Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension |
| CN105130855B (zh) | 2009-12-07 | 2018-05-25 | 约翰斯霍普金斯大学 | 二酰基化的羟基胺衍生物及其用途 |
| AU2010328234B2 (en) | 2009-12-07 | 2016-05-12 | Cardioxyl Pharmaceuticals, Inc. | N-acyloxysulfonamide and N-hydroxy-N-acylsulfonamide derivatives |
| JP6177246B2 (ja) | 2011-10-17 | 2017-08-09 | ザ・ジョンズ・ホプキンス・ユニバーシティ | ヒドロキシルアミンで置換された、ｈｎｏ供与体としてのメルドラム酸、バルビツール酸、及びピラゾロンの誘導体 |
| JP6306602B2 (ja) | 2012-11-01 | 2018-04-04 | ザ ジョンズ ホプキンス ユニバーシティ | 分子内環化−脱離による制御されたｈｎｏ放出 |
| SG10201802862WA (en) * | 2013-01-18 | 2018-05-30 | Cardioxyl Pharmaceuticals Inc | Pharmaceutical compositions comprising nitroxyl donors |
| EP2764868A1 (en) * | 2013-02-08 | 2014-08-13 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Combination of nitroprusside and a sulfide salt as an HNO-releasing therapeutic for the treatment or prevention of cardiovascular diseases |
| JP6531990B2 (ja) * | 2013-02-28 | 2019-06-19 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 心肺血行動態を改善するための無機亜硝酸塩 |
| EP2833611A1 (en) | 2013-07-31 | 2015-02-04 | Airbus Operations GmbH | Method of transmitting speech and digital data via an analog speech channel |
| ES2734060T3 (es) | 2014-01-17 | 2019-12-04 | Cardioxyl Pharmaceuticals Inc | Donadores de nitroxilo de N-hidroximetanosulfonamida |
| EP3148972B1 (en) | 2014-05-27 | 2019-08-21 | Cardioxyl Pharmaceuticals, Inc. | Pyrazolone derivatives as nitroxyl donors |
| US9464061B2 (en) | 2014-05-27 | 2016-10-11 | The Johns Hopkins University | N-hydroxylamino-barbituric acid derivatives |
| KR20180070672A (ko) | 2015-10-19 | 2018-06-26 | 카르디옥실 파마슈티칼스 인코포레이티드 | 니트록실 공여자로서의 n-히드록실술폰아미드 유도체 |
| US10723704B2 (en) | 2015-10-19 | 2020-07-28 | Cardioxyl Pharmaceuticals, Inc. | Pyrazolone derivatives as nitroxyl donors |
| EP3490975B1 (en) | 2016-07-28 | 2021-05-05 | The Johns Hopkins University | O-substituted hydroxamic acids |
-
2018
- 2018-01-02 WO PCT/US2018/012114 patent/WO2018128999A1/en not_active Ceased
- 2018-01-02 EP EP18705193.3A patent/EP3565544A1/en not_active Withdrawn
- 2018-01-02 SG SG10202107533RA patent/SG10202107533RA/en unknown
- 2018-01-02 CA CA3049003A patent/CA3049003A1/en active Pending
- 2018-01-02 CN CN201880014677.7A patent/CN110520116A/zh active Pending
- 2018-01-02 KR KR1020197022537A patent/KR20190103281A/ko not_active Ceased
- 2018-01-02 BR BR112019013702-5A patent/BR112019013702A2/pt not_active Application Discontinuation
- 2018-01-02 JP JP2019536215A patent/JP2020503356A/ja active Pending
- 2018-01-02 MX MX2019008000A patent/MX388684B/es unknown
- 2018-01-02 US US16/475,672 patent/US11083704B2/en active Active
- 2018-01-02 SG SG11201906145YA patent/SG11201906145YA/en unknown
- 2018-01-02 AU AU2018205621A patent/AU2018205621B2/en active Active
-
2019
- 2019-06-30 IL IL267728A patent/IL267728A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN110520116A (zh) | 2019-11-29 |
| JP2020503356A (ja) | 2020-01-30 |
| US20190343790A1 (en) | 2019-11-14 |
| AU2018205621B2 (en) | 2023-01-05 |
| KR20190103281A (ko) | 2019-09-04 |
| EP3565544A1 (en) | 2019-11-13 |
| MX2019008000A (es) | 2019-11-05 |
| CA3049003A1 (en) | 2018-07-12 |
| SG10202107533RA (en) | 2021-08-30 |
| AU2018205621A1 (en) | 2019-08-01 |
| MX388684B (es) | 2025-03-20 |
| SG11201906145YA (en) | 2019-08-27 |
| IL267728A (en) | 2019-08-29 |
| US11083704B2 (en) | 2021-08-10 |
| WO2018128999A1 (en) | 2018-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2811258T3 (es) | Derivados de N-hidroxilsulfonamida como nuevos donantes de nitroxilo fisiológicamente útiles | |
| JP2026021351A (ja) | 前立腺がんの内部放射線療法のための前立腺特異的膜抗原を標的とした高親和性薬剤 | |
| ES2882279T3 (es) | Composiciones farmacéuticas que comprenden donadores de nitroxilo | |
| ES2567630T3 (es) | Derivados de tetrahidroindol como inhibidores de la NADPH oxidasa | |
| JP2017531678A5 (https=) | ||
| RU2018101439A (ru) | Метаболически устойчивые аналоги cyp-эйкозаноидов для лечения кардиологических заболеваний | |
| BR112020016270A2 (pt) | Composto atuando como antibióticos | |
| IL292635A (en) | Prodrugs of Itacont and Methyl Itacont | |
| CN102807575B (zh) | 3-芳基-5-噻吩基-5H-噻唑并[3,2-a]嘧啶类衍生物及其应用 | |
| BR112019013702A2 (pt) | Método de administração de compostos doadores de nitroxila | |
| CA3156749A1 (en) | Use of itaconate and its derivatives/analogues to induce hair growth | |
| EA041774B1 (ru) | Способ введения нитроксилдонорных соединений | |
| JP2015533128A5 (https=) | ||
| BR122025025039A2 (pt) | Compostos de itaconato e itaconato de metila, composições farmacêuticas compreendendo os mesmos e usos dos ditos compostos no tratamento deinflamação | |
| BR122025025013A2 (pt) | Compostos de itaconato e itaconato de metila, composição farmacêutica compreendendo os ditos compostos e usos dos mesmo no tratamento de uma doença, transtorno ou condição associado com inflamação | |
| ES2566430B1 (es) | Esteres de di-benzoato y su uso terapéutico como moduladores negativos de canales de potasio KCa2/3 | |
| ZA200506130B (en) | Phenylacetamides and their use as glucokinase modulators | |
| WO2025014639A2 (en) | Neutral sphingomyelinase inhibitors | |
| RU2021122314A (ru) | Антигипертензивное полиольное соединение и его производное | |
| AR124638A1 (es) | Formas cristalinas de un inhibidor de la desoxicitidina cinasa y usos de estas | |
| US20210299093A1 (en) | Prophylactic or therapeutic agent for pulmonary hypertension comprising unsaturated 5-membered heterocycle-containing compound | |
| JPWO2004019946A1 (ja) | 細胞内ナトリウムイオン過蓄積抑制薬 | |
| JP2004137253A (ja) | 心筋炎の予防及び／又は治療のための医薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |